INFLUENCE OF HLA-DR PHENOTYPE ON TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION IN RENAL-TRANSPLANT RECIPIENTS

被引:12
作者
PECES, R
URRA, JM
DELATORRE, M
机构
[1] HOSP ALARCOS,SERV IMMUNOL,E-13002 CIUDAD REAL,SPAIN
[2] HOSP CENT ASTURIAS,OVIEDO,SPAIN
来源
NEPHRON | 1995年 / 71卷 / 02期
关键词
CYCLOSPORINE; DR; HLA; OKT3; RENAL TRANSPLANTATION; TUMOR NECROSIS FACTOR-ALPHA;
D O I
10.1159/000188709
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
In healthy subjects, previous studies have demonstrated a great interindividual variability in the ability for tumor necrosis factor-alpha (TNF-alpha) production. The gene for TNF-alpha is closely linked to and located in the major histocompatibility complex (MHC) and it has been suggested that these interindividual differences may be HLA related. Since TNF-alpha is likely to be an important mediator in renal allograft rejection, we investigated the role of HLA antigens on TNF-alpha production rates by peripheral blood mononuclear cells (PBMC) from renal transplant recipients during stable graft function. HLA-DR2-positive recipients showed significantly lower spontaneous TNF-alpha production than DR2-negative patients (p < 0.001). Upon stimulation with OKT3, HLA-DR2-positive patients also showed significantly lower TNF-alpha production than DR2-negative subjects (p < 0.001). HLA-DR3-positive recipients, however, showed significantly higher spontaneous TNF-alpha production than DR3-negative individuals (p < 0.05). These results suggest that differences in TNF-alpha production, both spontaneous and induced, may be due to the expression of certain DR allotypes.
引用
收藏
页码:180 / 183
页数:4
相关论文
共 17 条
[1]   ASSOCIATION BETWEEN HLA-DR2 AND PRODUCTION OF TUMOR NECROSIS FACTOR-ALPHA AND INTERLEUKIN-1 BY MONONUCLEAR-CELLS ACTIVATED BY LIPOPOLYSACCHARIDE [J].
BENDTZEN, K ;
MORLING, N ;
FOMSGAARD, A ;
SVENSON, M ;
JAKOBSEN, B ;
ODUM, N ;
SVEJGAARD, A .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1988, 28 (05) :599-606
[2]  
BENITO YA, 1993, KIDNEY INT, V44, P352
[3]  
CHATENOUD L, 1992, CLIN NEPHROL, V38, pS53
[4]   A HIGHLY SENSITIVE CELL-LINE, WEHI-164 CLONE 13, FOR MEASURING CYTOTOXIC FACTOR TUMOR-NECROSIS-FACTOR FROM HUMAN-MONOCYTES [J].
ESPEVIK, T ;
NISSENMEYER, J .
JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 95 (01) :99-105
[5]   INFLAMMATORY MEDIATOR RELEASE FROM HUMAN MONOCYTES VIA IMMOBILIZED FC-RECEPTORS - ITS POTENTIAL ROLE IN ADVERSE REACTIONS TO SYSTEMIC MONOCLONAL-ANTIBODY THERAPY [J].
HOFFMAN, T ;
TRIPATHI, AK ;
LEE, YL ;
BONVINI, E ;
GOLDING, B .
TRANSPLANTATION, 1992, 54 (02) :343-346
[6]   THE ROLE OF TUMOR-NECROSIS-FACTOR IN ALLOGRAFT-REJECTION .3. EVIDENCE THAT ANTI-TNF ANTIBODY THERAPY PROLONGS ALLOGRAFT SURVIVAL IN RATS WITH ACUTE REJECTION [J].
IMAGAWA, DK ;
MILLIS, JM ;
SEU, P ;
OLTHOFF, KM ;
HART, J ;
WASEF, E ;
DEMPSEY, RA ;
STEPHENS, S ;
BUSUTTIL, RW .
TRANSPLANTATION, 1991, 51 (01) :57-62
[7]   HERITABLE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II-ASSOCIATED DIFFERENCES IN PRODUCTION OF TUMOR NECROSIS FACTOR-ALPHA - RELEVANCE TO GENETIC PREDISPOSITION TO SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
JACOB, CO ;
FRONEK, Z ;
LEWIS, GD ;
KOO, M ;
HANSEN, JA ;
MCDEVITT, HO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (03) :1233-1237
[8]   RAISED SERUM LEVELS OF CACHECTIN/TUMOR NECROSIS FACTOR-ALPHA IN RENAL-ALLOGRAFT REJECTION [J].
MAURY, CPJ ;
TEPPO, AM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (04) :1132-1137
[9]   ENDOTOXIN-STIMULATED HUMAN MONOCYTE SECRETION OF INTERLEUKIN-1, TUMOR NECROSIS FACTOR-ALPHA, AND PROSTAGLANDIN-E2 SHOWS STABLE INTERINDIVIDUAL DIFFERENCES [J].
MOLVIG, J ;
BAEK, L ;
CHRISTENSEN, P ;
MANOGUE, KR ;
VLASSARA, H ;
PLATZ, P ;
NIELSEN, LS ;
SVEJGAARD, A ;
NERUP, J .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1988, 27 (06) :705-716
[10]  
NGUYEN DT, 1990, J IMMUNOL, V144, P3822